Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Mona Abaza

Concepts (151)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Otolaryngology
10
2021
86
3.030
Why?
Voice Disorders
9
2017
22
1.680
Why?
Personnel Selection
4
2019
72
1.360
Why?
Internship and Residency
8
2019
1053
1.330
Why?
Laryngoscopy
4
2023
97
0.810
Why?
Larynx
4
2015
57
0.760
Why?
Physicians, Women
1
2021
70
0.690
Why?
Learning
1
2023
403
0.620
Why?
Leadership
2
2021
357
0.570
Why?
Treatment Adherence and Compliance
1
2017
24
0.560
Why?
Career Choice
1
2018
207
0.520
Why?
Resilience, Psychological
1
2018
123
0.500
Why?
Deglutition Disorders
1
2017
134
0.490
Why?
Injections
1
2015
174
0.470
Why?
Education, Medical
1
2018
244
0.460
Why?
Simulation Training
1
2015
82
0.440
Why?
Voice
2
2017
12
0.430
Why?
Education, Medical, Undergraduate
1
2016
176
0.420
Why?
Occupational Diseases
2
2006
138
0.390
Why?
Patient Care Team
1
2017
605
0.390
Why?
Vocal Cords
4
2006
32
0.380
Why?
Burnout, Professional
1
2018
410
0.370
Why?
Carcinoma, Hepatocellular
2
2020
272
0.360
Why?
Hepatitis C
2
2020
238
0.350
Why?
Education, Medical, Graduate
3
2019
438
0.320
Why?
Liver Neoplasms
2
2020
640
0.300
Why?
Inhibin-beta Subunits
1
2006
5
0.260
Why?
Activins
1
2006
27
0.260
Why?
Schistosomiasis
1
2006
47
0.250
Why?
Job Application
2
2015
13
0.230
Why?
Insulin-Like Growth Factor I
1
2006
307
0.220
Why?
Postpoliomyelitis Syndrome
1
2001
4
0.190
Why?
Humans
26
2023
129650
0.180
Why?
Glypicans
1
2020
9
0.180
Why?
Dipeptidyl Peptidase 4
1
2020
13
0.170
Why?
Neurofibromatosis 2
2
1998
4
0.170
Why?
Equipment Design
2
2015
514
0.160
Why?
Voice Quality
2
2014
17
0.160
Why?
Pilot Projects
2
2019
1587
0.150
Why?
Disability Evaluation
1
2000
284
0.150
Why?
United States
4
2019
13903
0.140
Why?
Otolaryngologists
1
2017
11
0.140
Why?
Speech-Language Pathology
1
2017
19
0.140
Why?
Organizational Culture
1
2018
138
0.130
Why?
Educational Status
1
2019
470
0.130
Why?
Interviews as Topic
1
2019
717
0.130
Why?
Competitive Behavior
1
2015
41
0.120
Why?
Psychoses, Substance-Induced
2
2007
14
0.120
Why?
Dysphonia
1
2014
13
0.120
Why?
Faculty, Medical
1
2018
264
0.120
Why?
Speech Acoustics
1
2014
12
0.120
Why?
Clinical Clerkship
1
2016
95
0.110
Why?
Cell Division
1
1996
797
0.110
Why?
Female
13
2021
68776
0.110
Why?
Program Evaluation
1
2018
875
0.110
Why?
Egypt
2
2020
10
0.110
Why?
Clinical Competence
2
2019
1017
0.110
Why?
Electromyography
3
2007
381
0.110
Why?
School Admission Criteria
1
2013
23
0.110
Why?
Educational Measurement
1
2016
262
0.110
Why?
Attitude
1
2015
253
0.100
Why?
Correspondence as Topic
1
2012
14
0.100
Why?
Societies, Medical
1
2016
751
0.090
Why?
Students, Medical
1
2016
316
0.090
Why?
Writing
1
2012
91
0.090
Why?
Male
13
2018
63681
0.090
Why?
Surgeons
1
2015
261
0.090
Why?
Nasal Decongestants
2
2007
8
0.080
Why?
Histamine H1 Antagonists
2
2007
29
0.080
Why?
Anti-Ulcer Agents
2
2007
15
0.080
Why?
Biomedical Research
1
2015
638
0.080
Why?
Vocal Cord Paralysis
2
2005
29
0.070
Why?
Music
1
2006
39
0.060
Why?
Analgesics
1
2007
189
0.060
Why?
Movement Disorders
1
2005
52
0.060
Why?
Vagus Nerve Diseases
1
2002
1
0.050
Why?
Glucocorticoids
1
2007
575
0.050
Why?
Severity of Illness Index
3
2014
2742
0.050
Why?
Cough
1
2002
116
0.050
Why?
Laryngeal Diseases
1
2001
28
0.050
Why?
Amyloidosis
1
2001
42
0.050
Why?
Myasthenia Gravis
1
2001
21
0.040
Why?
Cicatrix
1
2001
59
0.040
Why?
alpha-Fetoproteins
1
2020
41
0.040
Why?
Middle Aged
7
2006
31154
0.040
Why?
Gastroesophageal Reflux
1
2002
232
0.040
Why?
Audiometry, Pure-Tone
2
1998
28
0.040
Why?
Parkinson Disease
1
2005
463
0.040
Why?
Adult
6
2006
35576
0.040
Why?
Drug Prescriptions
1
2001
248
0.040
Why?
Hepacivirus
1
2020
235
0.040
Why?
Ear Neoplasms
1
1998
8
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
253
0.040
Why?
Acute Disease
1
2001
980
0.040
Why?
Neurilemmoma
1
1998
23
0.040
Why?
Adipose Tissue
1
2001
592
0.030
Why?
Stroke
1
2005
1071
0.030
Why?
Spinal Neoplasms
1
1996
29
0.030
Why?
Reproducibility of Results
2
2014
3083
0.030
Why?
Speech Production Measurement
1
2014
12
0.030
Why?
Hearing Loss
1
1998
210
0.030
Why?
Follow-Up Studies
3
2001
4897
0.030
Why?
Judgment
1
2014
56
0.030
Why?
Area Under Curve
1
2014
304
0.030
Why?
Biomarkers, Tumor
1
2020
1181
0.030
Why?
Signal Processing, Computer-Assisted
1
2014
144
0.030
Why?
Observer Variation
1
2014
315
0.030
Why?
Speech Perception
1
2014
83
0.030
Why?
ROC Curve
1
2014
503
0.030
Why?
Prospective Studies
2
2014
7133
0.020
Why?
Aged
4
2005
22103
0.020
Why?
Predictive Value of Tests
1
2014
1952
0.020
Why?
Biomarkers
1
2020
3973
0.020
Why?
Patient Selection
1
2012
663
0.020
Why?
Age Factors
1
1996
3144
0.020
Why?
Magnetic Resonance Imaging
2
1998
3408
0.020
Why?
Algorithms
1
2014
1622
0.020
Why?
Case-Control Studies
1
2014
3381
0.020
Why?
Risk Assessment
2
2005
3240
0.010
Why?
Age Distribution
1
2005
372
0.010
Why?
Sex Distribution
1
2005
359
0.010
Why?
Cross-Sectional Studies
1
2015
5066
0.010
Why?
Brain
1
1996
2679
0.010
Why?
Surveys and Questionnaires
1
2015
5406
0.010
Why?
Hoarseness
1
2001
4
0.010
Why?
Laryngeal Muscles
1
2001
6
0.010
Why?
Pyridostigmine Bromide
1
2001
5
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
2001
38
0.010
Why?
Cholinesterase Inhibitors
1
2001
29
0.010
Why?
Injections, Intramuscular
1
2001
116
0.010
Why?
Biopsy, Needle
1
2001
189
0.010
Why?
Medical History Taking
1
2001
119
0.010
Why?
Drug Therapy
1
2001
80
0.010
Why?
Transplantation, Autologous
1
2001
211
0.010
Why?
Steroids
1
2001
158
0.010
Why?
Drug Utilization
1
2001
171
0.010
Why?
Incidence
1
2005
2644
0.010
Why?
Retrospective Studies
3
2001
14518
0.010
Why?
Speech Reception Threshold Test
1
1998
1
0.010
Why?
Diagnosis, Differential
1
2002
1434
0.010
Why?
Reflex, Vestibulo-Ocular
1
1998
10
0.010
Why?
Evoked Potentials, Auditory, Brain Stem
1
1998
51
0.010
Why?
Anti-Inflammatory Agents
1
2001
480
0.010
Why?
Prognosis
1
2005
3794
0.010
Why?
Adolescent
1
1996
20393
0.010
Why?
Chronic Disease
1
2002
1720
0.010
Why?
Child
1
1996
20883
0.010
Why?
Aged, 80 and over
1
2005
7086
0.010
Why?
Practice Patterns, Physicians'
1
2001
1266
0.010
Why?
Risk Factors
1
2001
9765
0.000
Why?
Treatment Outcome
1
2001
10230
0.000
Why?
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)